What this means
People with antibodies for rheumatoid arthritis who later got the disease had more of one immune cell type before symptoms began. Lab work hints these cells may help drive the disease, but this does not prove it.
Plain-English summary written by an AI model from the abstract. The original is below.
- Who it was tested in
- People with antibodies who later got RA, several other patient groups, and human cells in a lab
- Kind of research
- A study
The science
- Original title
- Senescent-like activated naive B cells contribute to progression to clinical rheumatoid arthritis.
- Authors
- Wu X, Zhang M, Moon JS et al.
- Journal
- Nature aging
- Published
- Oct 14, 2026
- Study type
- Study · in humans
- PMID
- 42875583 ↗
Abstract
Rheumatoid arthritis (RA) is an autoimmune disease marked by joint and systemic inflammation. Anticitrullinated protein antibodies identify an at-risk stage that precedes clinical RA, yet the mechanisms driving disease progression remain poorly understood. Here we show that anticitrullinated-protein-antibody-positive individuals who progressed to RA exhibited a marked expansion of CXCR5+CD69+-activated naive B cells (aNAVs) before disease onset. These cells displayed inflammatory and senescent-like transcriptional programs and expressed polyreactive, autoreactive IgM B cell receptors. The expansion, activation and senescent-like phenotype of aNAVs were validated in multiple independent preclinical RA cohorts, and aNAVs were detectable in RA synovium. In vitro, aNAVs stimulated with citrullinated antigens promoted T cell activation in a human-leukocyte-antigen-dependent manner. Chronic exposure to citrullinated antigens and CpG (an innate immune stimulant) synergistically drove activation and senescent-like programming in naive B cells from individuals with RA. These findings identify senescent-like aNAVs as potential contributors and therapeutic targets for RA prevention.
Wu X, Zhang M, Moon JS et al. Senescent-like activated naive B cells contribute to progression to clinical rheumatoid arthritis. Nature aging. 2026. doi:10.1038/s43587-026-01236-6. PMID: 42875583. https://pubmed.ncbi.nlm.nih.gov/42875583/